Identification of an AP2-family Protein That Is Critical for Malaria Liver Stage Development

Liver-stage malaria parasites are a promising target for drugs and vaccines against malaria infection. However, little is currently known about gene regulation in this stage. In this study, we used the rodent malaria parasite Plasmodium berghei and showed that an AP2-family transcription factor, designated AP2-L, plays a critical role in the liver-stage development of the parasite. AP2-L-depleted parasites proliferated normally in blood and in mosquitoes. However, the ability of these parasites to infect the liver was approximately 10,000 times lower than that of wild-type parasites. In vitro assays showed that the sporozoites of these parasites invaded hepatocytes normally but that their development stopped in the middle of the liver schizont stage. Expression profiling using transgenic P. berghei showed that fluorescent protein-tagged AP2-L increased rapidly during the liver schizont stage but suddenly disappeared with the formation of the mature liver schizont. DNA microarray analysis showed that the expression of several genes, including those of parasitophorous vacuole membrane proteins, was significantly decreased in the early liver stage of AP2-L-depleted parasites. Investigation of the targets of this transcription factor should greatly promote the exploration of liver-stage antigens and the elucidation of the mechanisms of hepatocyte infection by malaria parasites.

[1]  A. Vaughan,et al.  Superior antimalarial immunity after vaccination with late liver stage-arresting genetically attenuated parasites. , 2011, Cell host & microbe.

[2]  Manuel Llinás,et al.  The Apicomplexan AP2 family: integral factors regulating Plasmodium development. , 2011, Molecular and biochemical parasitology.

[3]  Xinxia Peng,et al.  SAP1 is a critical post‐transcriptional regulator of infectivity in malaria parasite sporozoite stages , 2011, Molecular microbiology.

[4]  Manuel Llinás,et al.  Identification and Genome-Wide Prediction of DNA Binding Specificities for the ApiAP2 Family of Regulators from the Malaria Parasite , 2010, PLoS pathogens.

[5]  Masao Yuda,et al.  Transcription factor AP2‐Sp and its target genes in malarial sporozoites , 2010, Molecular microbiology.

[6]  Masao Yuda,et al.  Identification of a transcription factor in the mosquito‐invasive stage of malaria parasites , 2009, Molecular microbiology.

[7]  K. Matuschewski,et al.  A Sporozoite Asparagine-Rich Protein Controls Initiation of Plasmodium Liver Stage Development , 2008, PLoS pathogens.

[8]  I. Coppens,et al.  Targeted deletion of SAP1 abolishes the expression of infectivity factors necessary for successful malaria parasite liver infection , 2008, Molecular microbiology.

[9]  Xinxia Peng,et al.  A combined transcriptome and proteome survey of malaria parasite liver stages , 2008, Proceedings of the National Academy of Sciences.

[10]  L. Aravind,et al.  Comparative genomics of transcription factors and chromatin proteins in parasitic protists and other eukaryotes. , 2008, International journal for parasitology.

[11]  S. Kappe,et al.  Protracted sterile protection with Plasmodium yoelii pre-erythrocytic genetically attenuated parasite malaria vaccines is independent of significant liver-stage persistence and is mediated by CD8+ T cells. , 2007, The Journal of infectious diseases.

[12]  K. Matuschewski,et al.  High efficiency transfection of Plasmodium berghei facilitates novel selection procedures. , 2006, Molecular and biochemical parasitology.

[13]  Y. Chinzei,et al.  Two proteins with 6‐cys motifs are required for malarial parasites to commit to infection of the hepatocyte , 2005, Molecular microbiology.

[14]  M. Madan Babu,et al.  Discovery of the principal specific transcription factors of Apicomplexa and their implication for the evolution of the AP2-integrase DNA binding domains , 2005, Nucleic acids research.

[15]  S. Kappe,et al.  Plasmodium liver stage developmental arrest by depletion of a protein at the parasite-host interface. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[16]  S. Kappe,et al.  Genetically modified Plasmodium parasites as a protective experimental malaria vaccine , 2005, Nature.

[17]  Masao Yuda,et al.  Cell-Passage Activity Is Required for the Malarial Parasite to Cross the Liver Sinusoidal Cell Layer , 2004, PLoS biology.

[18]  Patricia De la Vega,et al.  Protection of humans against malaria by immunization with radiation-attenuated Plasmodium falciparum sporozoites. , 2002, The Journal of infectious diseases.

[19]  U. Krzych,et al.  MHC class I-dependent presentation of exoerythrocytic antigens to CD8+ T lymphocytes is required for protective immunity against Plasmodium berghei. , 1996, Journal of immunology.

[20]  V. Nussenzweig,et al.  γ Interferon, CD8+ T cells and antibodies required for immunity to malaria sporozoites , 1987, Nature.